Pineapple Express Cannabis (PNXP) Common Equity (2018 - 2025)
Pineapple Express Cannabis' (PNXP) quarterly Common Equity came in at -$8.2 million in Q4 2025, down 28708.87% year-on-year from N/an in Q4 2024, and little changed quarter-over-quarter from -$8.2 million in Q3 2025.
Pineapple Express Cannabis (PNXP) Common Equity (2018 - 2025) Analysis & Trends
Pineapple Express Cannabis has disclosed Common Equity across 8 years of filings, most recently posting -$8.2 million for Q4 2025.
- Common Equity for Q4 2025 came in at -$8.2 million, down 28708.87% year-over-year; the trailing twelve-month figure through Oct 2025 was -$8.2 million (down 28708.87% YoY), and the FY2025 annual result was -$2079.0, up 86.95% from the prior year.
- Common Equity came in at -$8.2 million for Q4 2025 at Pineapple Express Cannabis, roughly flat from -$8.2 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.1 million in Q4 2023 to a low of -$8.2 million in Q2 2025.
- The 5-year median for Common Equity is -$40531.5 (2021), against an average of -$1.2 million.
- Across the five-year window, Common Equity soared 1622.11% in 2023 and slumped 32337.33% in 2025, its largest moves.
- Pineapple Express Cannabis' Common Equity stood at -$53505.0 in 2021, then tumbled by 30.2% to -$69661.0 in 2022, then jumped by 1622.11% to $1.1 million in 2023, then plunged by 97.31% to $28502.0 in 2024, then plunged by 28708.87% to -$8.2 million in 2025.
- The last three Common Equity figures came in at -$8.2 million (Q4 2025), -$8.2 million (Q3 2025), and -$8.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Pineapple Express Cannabis | - | - | - | -8.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -8.15 Mn |
| Jul 31, 2025 | -8.18 Mn |
| Apr 30, 2025 | -8.21 Mn |
| Jan 31, 2025 | -2,079.00 |
| Oct 31, 2024 | 28,502.00 |
| Jul 31, 2024 | 29,750.00 |
| Apr 30, 2024 | 25,458.00 |
| Jan 31, 2024 | -15,926.00 |
| Oct 31, 2023 | 1.06 Mn |
| Jul 31, 2023 | 919,158.00 |
| Apr 30, 2023 | 305,245.00 |
| Jan 31, 2023 | -544,350.00 |
| Oct 31, 2022 | -69,661.00 |
| Jul 31, 2022 | -65,892.00 |
| Apr 30, 2022 | -64,532.00 |
| Jan 31, 2022 | -58,905.00 |
| Oct 31, 2021 | -53,505.00 |
| Jul 31, 2021 | -52,478.00 |
| Apr 30, 2021 | -28,585.00 |
| Jan 31, 2021 | -15,913.00 |